Clinical Diabetology最新文献

筛选
英文 中文
The Effect of Stage-Matched Educational Intervention on Behavior Change and Glycemic Control in Elderly Patients with Diabetes 阶段匹配教育干预对老年糖尿病患者行为改变和血糖控制的影响
IF 0.7
Clinical Diabetology Pub Date : 2022-08-31 DOI: 10.5603/dk.a2022.0030
Azadeh Hajipour, M. Javadi, I. Mohammadi Zeidi
{"title":"The Effect of Stage-Matched Educational Intervention on Behavior Change and Glycemic Control in Elderly Patients with Diabetes","authors":"Azadeh Hajipour, M. Javadi, I. Mohammadi Zeidi","doi":"10.5603/dk.a2022.0030","DOIUrl":"https://doi.org/10.5603/dk.a2022.0030","url":null,"abstract":"Objective: Diabetes is a chronic and common global dis-ease that requires particular care behaviors for the rest of life. People with diabetes can be trained to achieve optimal self-care. The present study was conducted to determine the effect of stage-matched educational intervention on behavior change and glycemic control in elderly patients with diabetes. Matherials and methods: In this controlled clinical trial, 110 type 2 elderly patients with diabetes were selected randomly from health centers in Malard city, Iran, and were assigned to the control and experimental group equally. Data collection instruments were: demographics questions, scales to assess transtheoretical model constructs and stage of change, and blood samples for determining FBS and HbA1c. The mentioned variables were measured before, 1, and 3 months after the stage-matched educational intervention. The educational intervention consisted of 2 group intensive training sessions of about 45 minutes and daily messages via mobile phone for 3 months. The educational topics were about healthy diet and caring behaviors. Data were analyzed using SPSS 25.0 and independent & paired t-test, chi-square, one-way ANOVA, and ANCOVA. The significance level was con sidered less than 0.05. Results: The mean age of study participants was (66.5 ± 3.91) years. Also, the average duration of diabetes was (7.18 ± 4.21) years, and 50% had a Junior high school education. A significant decrease was found in mean FBS (from 187 ± 43.4 to 136.42 ± 36.34, p < 0.05) and HbA1c (from 8.28 ± 1.26 to 7.26 ± ± 1.10, p < 0.05) in the experimental group, and also the mean of self-care behaviors in the experimental group increased significantly from baseline (from 1.51 ± ± 1.71 to 1.45 ± 0.92, p < 0.05). Conclusions: Educational intervention based on the stages-of-change model can improve glycemic control and behaviors related to controlling diabetes, so it is necessary to pay attention to essential psychological variables in designing educational interventions in order to control blood glucose in patients with diabetes. (Clin Diabetol 2022, 11; 4: 232–238)","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":"1 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76120400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Clinical Outcomes of IDF-DAR Practical Guidelines Adaptation for the Management of Type 2 Diabetes: Results from a Real-world Clinical Study in India IDF-DAR实用指南适用于2型糖尿病管理的临床结果:来自印度真实世界临床研究的结果
IF 0.7
Clinical Diabetology Pub Date : 2022-08-31 DOI: 10.5603/dk.a2022.0034
S. Bhattacharyya
{"title":"Clinical Outcomes of IDF-DAR Practical Guidelines Adaptation for the Management of Type 2 Diabetes: Results from a Real-world Clinical Study in India","authors":"S. Bhattacharyya","doi":"10.5603/dk.a2022.0034","DOIUrl":"https://doi.org/10.5603/dk.a2022.0034","url":null,"abstract":"","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":"16 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85799059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
First Clinical Manifestations of Type 1 Diabetes Mellitus Among Hospitalized Children in Yazd, Iran: A Single-Center Experience 伊朗亚兹德住院儿童中1型糖尿病的首次临床表现:单中心经验
IF 0.7
Clinical Diabetology Pub Date : 2022-08-31 DOI: 10.5603/dk.a2022.0036
M. Ordooei, Marzie Vaghefi, Zahra Nafei, Shakiba Abbaszade
{"title":"First Clinical Manifestations of Type 1 Diabetes Mellitus Among Hospitalized Children in Yazd, Iran: A Single-Center Experience","authors":"M. Ordooei, Marzie Vaghefi, Zahra Nafei, Shakiba Abbaszade","doi":"10.5603/dk.a2022.0036","DOIUrl":"https://doi.org/10.5603/dk.a2022.0036","url":null,"abstract":"Address for correspondence: Zahra Nafei Children Growth Disorder Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran email: nafeiy@yahoo.com Clinical Diabetology 2022, 11; 4: 294–295 DOI: 10.5603/DK.a2022.0036 Received: 31.05.2022 Accepted: 24.06.2022 Mahtab Ordooei1, Marzie Vaghefi1, Zahra Nafei1, Shakiba Abbaszade2 1Children Growth Disorder Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran 2Department of Pediatrics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":"193 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83721002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association Between Glycemic Control Status and Serum Level of Vitamin D3 in Patients with Type 2 Diabetes: A Cross-Sectional Study 2型糖尿病患者血糖控制状况与血清维生素D3水平之间的关系:一项横断面研究
IF 0.7
Clinical Diabetology Pub Date : 2022-08-31 DOI: 10.5603/dk.a2022.0032
Ehsan Aliniagerdroudbari, Zahra Farhangian, S. Babaniamansour, M. Niroomand
{"title":"Association Between Glycemic Control Status and Serum Level of Vitamin D3 in Patients with Type 2 Diabetes: A Cross-Sectional Study","authors":"Ehsan Aliniagerdroudbari, Zahra Farhangian, S. Babaniamansour, M. Niroomand","doi":"10.5603/dk.a2022.0032","DOIUrl":"https://doi.org/10.5603/dk.a2022.0032","url":null,"abstract":"Objective: This study aimed to assess the association between glycemic control status and serum levels of vitamin D3 in Iranian patients with type 2 diabetes (T2D). Materials and methods: This was a cross-sectional study on 452 patients with T2D in Tehran, Iran, performed between September 2019 and September 2020. We assessed the diabetes laboratory test and vitamin D3 level in all participants using the Enzymatic Glucose Oxidase method. Data were analyzed using SPSS version 24. Results: a total of 452 patients were enrolled in this study (mean age: 59.4 ± 11.4 years, 63.5% females). Vitamin D deficiency was reported in half of the partici -pants. Deficient vitamin D was significantly associated with higher mean level of hemoglobin A1c, fasting plasma glucose, total cholesterol, and low-density lipoprotein-cholesterol (p < 0.05). Multiple regression showed that the level of vitamin D3 could be a good predictor of hemoglobin A1c after adjusting for confounding variables affecting the hemoglobin A1c (regression coefficient: 0.442, 95% CI, 0.072–0.811, p = 0.063). Conclusions: With the alarming rates of vitamin D deficiency in patients with T2D, there was a significant direct association between vitamin D3 and hemoglobin A1c levels before and after adjusting for the associated factors. (Clin Diabetol 2022, 11; 4: 262–268)","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":"9 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90426964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Safety and Effectiveness of a Polysaccharide Extracted from Rosa Canina in Patients with NAFLD: A Randomized Trial 犬玫瑰多糖对NAFLD患者的安全性和有效性:一项随机试验
IF 0.7
Clinical Diabetology Pub Date : 2022-08-31 DOI: 10.5603/dk.a2022.0028
G. Bahrami, R. Naseri, M. Khosravifar, Soraya Sajadimajd, Bahareh Mohammadi, F. Heydarpour, Sanaz Cheraghialiakbari
{"title":"The Safety and Effectiveness of a Polysaccharide Extracted from Rosa Canina in Patients with NAFLD: A Randomized Trial","authors":"G. Bahrami, R. Naseri, M. Khosravifar, Soraya Sajadimajd, Bahareh Mohammadi, F. Heydarpour, Sanaz Cheraghialiakbari","doi":"10.5603/dk.a2022.0028","DOIUrl":"https://doi.org/10.5603/dk.a2022.0028","url":null,"abstract":"Objective: Non-alcoholic fatty liver (NAFL) is a common pathology of hepatocytes due to the accumulation of fat which is predominantly implicated in obesity. Due to the multifaceted characterization of fatty liver and no effective treatment, this study was aimed to assess the protective effect of a polysaccharide in NAFL patients. Materials and methods: Polysaccharide fraction was isolated from Rosa canina and administered to 33 NAFL patients for 90 days. Demographic information, liver ultrasonography, and the activity of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) enzymes were studied. Data were analyzed with the use of SPSS version 21 (SPSS, Inc.) All data were shown as means ± SDs and p < 0.05 was considered as significant. Results: After 90-day prescription, the weight loss, reduced activity of ALT and AST as well as changing the echogenicity of the liver from grades of 3, 2, and 1 to 2, 1 and normal, respectively, were observed in patients compared to the baseline (p ≤ 0.05). In ad-dition, there were no visible side effects in patients during drug consumption. Conclusions: The data indicated that polysaccharide fraction with no obvious side effects is significantly able to protect the liver from steatosis in patients with NAFL disease. However, further information is required to better conclude on the effectiveness of the isolated polysaccharide as a promising fatty liver drug. (Clin Diabetol 2022, 11; 4: 239–244)","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":"27 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85492989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
GLP-1 Receptor Agonists Critical Review: Revisiting Its Positioning for Type 2 Diabetes Mellitus in Routine Clinical Practice in India GLP-1受体激动剂:在印度常规临床实践中重新审视其在2型糖尿病中的定位
IF 0.7
Clinical Diabetology Pub Date : 2022-08-31 DOI: 10.5603/dk.a2022.0026
R. Rajput, B. Sinha, S. Lodha, P. Deb, Sambit Das, S. Agarwal, A. Das, N. Thomas
{"title":"GLP-1 Receptor Agonists Critical Review: Revisiting Its Positioning for Type 2 Diabetes Mellitus in Routine Clinical Practice in India","authors":"R. Rajput, B. Sinha, S. Lodha, P. Deb, Sambit Das, S. Agarwal, A. Das, N. Thomas","doi":"10.5603/dk.a2022.0026","DOIUrl":"https://doi.org/10.5603/dk.a2022.0026","url":null,"abstract":"Objective: Despite the benefit–risk ratio favoring glucagon-like peptide-1 receptor agonists (GLP-1 RAs), knowledge and awareness is lacking among patients and physicians, particularly in India. The current review provides an overview of GLP-1 RAs and the opinion of a group of healthcare practitioners (HCPs) and independent consultants across India on the evidence for using GLP-1 RAs and its applicability to the Indian population. Materials and methods: A panel of eight HCPs met virtually on December 12–13, 2020 met as part of the Diabetes Research Society (DIABAID). They examined and critically discussed the current research on the use of GLP-1 RAs in the management of T2DM. Results: The panel observed that recent diabetes guidelines and recommendations have shifted toward a more individualised and CV risk-focused approach to T2DM management. They proposed that 1) GLP-1 RAs are ideal cardio-metabolic drugs that address multiple aspects of the T2DM; 2) to bring up GLP-1 RAs as early treatment option in discussions with patients; 3) in T2DM patients with a high CV risk or established ASCVD, CKD, or HF, GLP-1 RAs with proven CVD benefits should be initiated; 4) including oral semaglutide in international treatment recommendation guidelines to improve patient and HCP understanding and adaptability; and 5) patient-physician dialogues will be critical in incorporating GLP-1 RAs earlier in the treatment paradigm for effective T2DM management. Conclusions: The recommendations on using GLP-1 RAs and the associated benefits and risks of these drugs comprise essential considerations for using such medications in the Indian population. (Clin Diabetol 2022, 11; 4: 269–293)","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":"119 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79423496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Peer Group-Based Training Using Health Belief Model on Quality of Life and Foot Ulcer Self-Care Behaviour in Patients with Type 2 Diabetes: A Randomized Controlled Clinical Trial 基于同伴群体的健康信念模型训练对2型糖尿病患者生活质量和足溃疡自我护理行为的影响:一项随机对照临床试验
IF 0.7
Clinical Diabetology Pub Date : 2022-08-31 DOI: 10.5603/dk.a2022.0031
Roya Mehdizade Tazangi, M. Bijani, Shahnaz Karimi, M. Naghizadeh, A. K. Jeihooni, Mohammadhossein Rahimzahedi
{"title":"The Effect of Peer Group-Based Training Using Health Belief Model on Quality of Life and Foot Ulcer Self-Care Behaviour in Patients with Type 2 Diabetes: A Randomized Controlled Clinical Trial","authors":"Roya Mehdizade Tazangi, M. Bijani, Shahnaz Karimi, M. Naghizadeh, A. K. Jeihooni, Mohammadhossein Rahimzahedi","doi":"10.5603/dk.a2022.0031","DOIUrl":"https://doi.org/10.5603/dk.a2022.0031","url":null,"abstract":"Objective: The present study was aimed at investigat-ing the effect of peer group-based training (PGBT) using the health belief model (HBM) on the quality of life (QOL) and foot ulcer self-care behavior in patients with type 2 diabetes. Materials and methods: The present study was a randomized controlled clinical trial performed on patients with type 2 diabetes who were referred to the Diabetic Care Clinic in Shiraz (Iran) from September 2019 to June 2020. A total of 70 patients participated in the study and were randomly assigned to peer training (n = 35) and control groups (n = 35). Diabetes Quality of Life, and diabetes self-care behaviors, which were completed by both groups before, immediately, 1 month, and 3 months after the intervention. The data were analyzed using the Chi-square test, paired t-test, independent t-test, ANOVA, and descriptive statistical methods. P < 0.05 was considered statistically significant. Results: The results showed that mean scores of QOL, constructs of HBM (awareness, perceived susceptibility, perceives severity, perceived benefit, self-care behavior, and foot care) before the intervention did not reveal a significant difference between the two groups, but immediately one month after the educational intervention, the mean values for the intervention group were significantly higher than the control group (p < 0.05). Conclusion: PGBT using HBM was effective in increasing the mean score of QOL and self-care behavior in patients with type 2 diabetes. Thus, this method is recommended to be utilized alongside other methods to train patients. (Clin Diabetol 2022, 11; 4: 251–261)","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":"13 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84321037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vitamin D and Diabetes: Association vs. Causation? 维生素D与糖尿病:相关性与因果关系?
IF 0.7
Clinical Diabetology Pub Date : 2022-08-31 DOI: 10.5603/dk.a2022.0038
A. V. Raveendran
{"title":"Vitamin D and Diabetes: Association vs. Causation?","authors":"A. V. Raveendran","doi":"10.5603/dk.a2022.0038","DOIUrl":"https://doi.org/10.5603/dk.a2022.0038","url":null,"abstract":"","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":"13 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85183419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changes in Lipid Profile, Liver Enzymes and Inflammatory Factors Following Oral Supplementation with Propolis in Patients with Type 2 Diabetes 2型糖尿病患者口服蜂胶后血脂、肝酶和炎症因子的变化
IF 0.7
Clinical Diabetology Pub Date : 2022-08-31 DOI: 10.5603/dk.a2022.0033
F. Afsharpour, M. Javadi, S. Hashemipour, Y. Koushan, Hossein Khadem Haghighian
{"title":"Changes in Lipid Profile, Liver Enzymes and Inflammatory Factors Following Oral Supplementation with Propolis in Patients with Type 2 Diabetes","authors":"F. Afsharpour, M. Javadi, S. Hashemipour, Y. Koushan, Hossein Khadem Haghighian","doi":"10.5603/dk.a2022.0033","DOIUrl":"https://doi.org/10.5603/dk.a2022.0033","url":null,"abstract":"","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":"86 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72926653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between Hyperglycemic Crisis with Major Cardiovascular Events in Patients with Diabetes: A Single Center Retrospective Cohort Study 糖尿病患者高血糖危象与主要心血管事件的关系:一项单中心回顾性队列研究
IF 0.7
Clinical Diabetology Pub Date : 2022-06-30 DOI: 10.5603/dk.a2022.0019
I. Paulus, Jourdan Wirasugianto, N. L. P. P. Sanjiwani, I. Supadmanaba, I. Semadi, K. Suastika
{"title":"Association between Hyperglycemic Crisis with Major Cardiovascular Events in Patients with Diabetes: A Single Center Retrospective Cohort Study","authors":"I. Paulus, Jourdan Wirasugianto, N. L. P. P. Sanjiwani, I. Supadmanaba, I. Semadi, K. Suastika","doi":"10.5603/dk.a2022.0019","DOIUrl":"https://doi.org/10.5603/dk.a2022.0019","url":null,"abstract":"","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":"16 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80852416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信